BEIJING, Nov. 4, 2022
/PRNewswire/ -- The National Cancer Institute(NCI)'s SEER
statistics show that breast cancer recurrence rate is as much as
30%. According to the 2022 White Paper on the Quality of Life of
Breast Cancer Patients in China,
more than 70% of breast cancer patients are worried about
recurrence. For these people, Waterdrop launched insurance against
breast cancer recurrence.
This product is available to people aged between 18 and 65 years
old, and the age limit may be extended to 75 when the insured
renews his/her policy without interruption. It features a low
threshold, flexible insured amount, wide coverage, and no
deductible for Anti-Cancer Drugs.
Highlight 1: Low threshold, available to Stage 0-III
Most insurance products against breast cancer recurrence are
offered only to people at Stages 0-II, this product of Waterdrop is
open to people at Stages 0-III, with no subtype restrictions.
Similar products in the market are sometimes unavailable to
people with other serious diseases. This product is less
restrictive in this regard.
Highlight 2: Wide coverage
Some similar products only provide rationed payment and some
only cover actual medical expenses. This product offers up to
RMB 300,000 of insurance benefits for
the recurrence of breast cancer, and the insured may also choose
RMB 300,000 of benefits for
healthcare and RMB 500,000 of
benefits for wonder drugs.
Highlight 3: 100% payment within the coverage, no deductible for
Anti-Cancer Drugs
Highlight 4: Reasonable pricing for different stages and
types
The premium of this product varies with stage and type so that
people exposed to different risks can be insured at more reasonable
prices.
Highlight 5: Value-added services
This product also provides the insured with services like
psychological counseling and healthcare management to help them to
have a better mindset and scientific healthcare management.
An insider from Waterdrop said, "the insurance against breast
cancer recurrence will serve as a firewall for the insured,
relieving their financial pressure when the disease recurs. We will
continue co-developing more inclusive insurance products with more
industry partners to satisfy the protection needs of more
people."
About Waterdrop Inc.
Waterdrop Inc. (NYSE: WDH) is a leading technology platform
dedicated to insurance and healthcare service with a positive
social impact. Founded in 2016, with the comprehensive coverage of
Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding,
Waterdrop aims to bring insurance and healthcare service to
billions through technology. For more information, please visit
www.waterdrop-inc.com.
Safe Harbor Statement
This press release contains statements that may constitute
"forward-looking" statements pursuant to the "safe harbor"
provisions of the U.S. Private Securities Litigation Reform Act of
1995. These forward-looking statements can be identified by
terminology such as "will," "expects," "anticipates," "aims,"
"future," "intends," "plans," "believes," "estimates," "likely to,"
and similar statements. Statements that are not historical facts,
including statements about Waterdrop's beliefs, plans, and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties. Further
information regarding these and other risks is included in
Waterdrop's filings with the SEC. All information provided in this
press release is as of the date of this press release, and
Waterdrop does not undertake any obligation to update any
forward-looking statement, except as required under applicable
law.
For investor inquiries, please contact:
Waterdrop Inc.
Xiaojiao Cui
IR@shuidi-inc.com
For media inquiries, please contact:
Waterdrop Inc.
PR Department
press@shuidi-inc.com
View original
content:https://www.prnewswire.com/news-releases/waterdrop-launches-insurance-against-breast-cancer-recurrence-301668897.html
SOURCE Waterdrop Inc.